Project Grant R21HD116151
- This $455,824.20 Project Grant from the National Center for Advancing Translational Sciences will fund research to identify direct interactions between understudied G protein-coupled receptors (GPCRs) and protein kinase A (PKA) isoforms. The University of Utah will utilize the National Institutes of Health's existing Prestwick Chemical Library and NanoBRETT kinase assay platforms to develop a high-throughput screening assay for GPCR-PKA interactions. This assay will then be applied to...
- This $644,900 Project Grant, awarded July 1, 2025, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859), supports fundamental research on PAS (Period-Arnt-Singleminded) domain proteins and their signaling mechanisms. The award, administered by the Research Foundation of the City University of New York's Advanced Science Research Center and scheduled for completion by June 30, 2030, will deliver structural, biophysical,...
- This Project Grant award from the National Center for Advancing Translational Sciences (NCATS), under CFDA Program 93.350, provides $158,750.00 to the University of Texas at Austin to conduct research on the function of the CACNA2D4 gene and its role in inherited retinal dystrophies. The overarching goal is to gain insight into the pathophysiological mechanisms of CACNA2D4-associated inherited retinal disorders by elucidating the structure-function relationships of the A2D-4 protein, which is...
- This Project Grant from the National Institutes of Health's National Cancer Institute totaling $668,151 will support the development of highly multiplexed live-cell G protein-coupled receptor (GPCR) arrays for glioma drug discovery. Spectragenetics, Inc. will deploy an automated multiplexed live-cell assay to detect and quantify agonist and inverse-agonist activities against 55 GPCRs known to be upregulated or downregulated in human gliomas. The assay will be used to screen 48 established...
- Federal Grant Award Summary Cold Spring Harbor Laboratory received a $732,475 Project Grant awarded on August 1, 2025, by the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project, titled "Structural and Functional Insights into Large-Pore Channels," will be conducted through April 30, 2030, at the laboratory's facility in Cold Spring Harbor, New York....
- This $429,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research to uncover the structural and molecular mechanisms underlying calcium (Ca2+) signaling at contact sites between the endoplasmic reticulum (ER) and mitochondria in neurons. The research aims to utilize cutting-edge cryogenic electron tomography techniques to...
- This $429,000 Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports fundamental research on the structure and function of ATP-sensitive potassium (KATP) channels at Oregon Health & Science University. The award, effective April 1, 2026 through March 31, 2031, funds investigator-initiated research aimed at understanding the structural mechanisms by which KATP...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded Emory University a $430,375 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to study disease-associated mutations and ligand activation of the adhesion G protein-coupled receptor ADGRB2. The key objectives are to: Investigate newly identified patient mutations in the ADGRB2 gene that are associated with spastic paraparesis and other neurological symptoms,...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $378,750.00 to Saint Louis University to conduct research on YCX1, a newly discovered protein involved in calcium signaling. The project aims to: Characterize the biochemical activity and regulation of YCX1, a putative calcium/cation exchanger, and its role in calcium signaling within the endoplasmic reticulum and Golgi....
- This $370,575 project grant from the National Institutes of Health National Cancer Institute Cancer Biology Research program (CFDA 93.396) will fund research at the University of Cincinnati investigating the molecular mechanisms of growth in pancreatic cancer with GNAS mutations. The grant supports studies from August 1, 2022 to July 31, 2027 to further the understanding of the oncogenic functions of mutant GNAS and its downstream signaling pathways. Specifically, the research will illuminate...
PLEIOTROPIC PATHWAYS OF EXTRACELLULAR CALCIUM SENSING - SUMMARY THE HUMAN CALCIUM-SENSING RECEPTOR (CASR) DETECTS FLUCTUATIONS IN THE CIRCULATING CA2+ CONCENTRATION AND MAINTAINS EXTRACELLULAR CA2+ HOMEOSTASIS BY REGULATING PARATHYROID HORMONE SECRETION. IN ADDITION, THE RECEPTOR MEDIATES A WIDE RANGE OF CELLULAR PROCESSES UNRELATED TO CA2+ BALANCE SUCH AS FETAL DEVELOPMENT. MALFUNCTION OF CASR IS ASSOCIATED WITH A VAREITY OF CA2+ HOMEOSTATIC DISORDERS INCLUDING POTENTIALLY LIFE THREATENING NEONATAL HYPERCALCAEMIC CONDITIONS. ABNORMALITIES IN THE CASR GENE HAS ALSO BEEN IMPLICATED IN OTHER DISEASES INCLUDING CANCER AND ALZHEIMER'S DISEASE. THE FUNCTIONAL DIVERSITY OF THE CASR RESULTS FROM ITS ABILITY TO SIGNAL THROUGH ALL FOUR SUBTYPES OF G PROTEINS, INCLUDING GQ/11, GI/O, GS, AND G12/13. WE HAVE USED CRYO-ELECTRON MICROSCOPY (EM) TO SOLVE THE STRUCTURES OF ACTIVE CASR COMPLEXED WITH DIFFERENT G PROTEINS. IN THIS APPLICATION, WE WILL BUILD UPON THIS STRUCTURAL DATA TO EXPLORE HOW THE CASR ACHIEVES G PROTEIN SELECTIVITY AND PROMISCUITY USING STRUCTURE-BASED FUNCTIONAL STUDIES. WE WILL ALSO ASSESS THE SIGNALING EFFECTS OF NATURALLY OCCURRING MUTATIONS IN THE RECEPTOR THAT ARE LINKED TO CA2+ METABOLIC AND OTHER DISORDERS. WE WILL DETERMINE THE IMPACT OF THESE MUTATIONS ON CELL SURFACE EXPRESSION AS WELL AS ACTIVATION OF EACH OF THE FOUR G PROTEIN FAMILIES. IN ADDITION, WE WILL EXPLORE THE ABILITY OF POSITIVE AND NEGATIVE ALLOSTERIC MODULATORS TO NORMALIZE RECEPTOR SIGNALING. FINALLY, WE WILL INITIATE STRUCTURAL STUDIES TO UNDERSTAND THE MECHANISTIC BASIS FOR NATURALLY OCCURRING MUTATIONS THAT DIFFERENTIALLY IMPACT THE VARIOUS G PROTEIN SUBTYPES. OUR WORK WILL ELUCIDATE THE INTRACELLULAR SIGNALING MECHANISMS OF THE CASR AND MAP OUT THE FUNCTIONAL ROLES OF DISEASE MUTATIONS. THE INFORMATION GATHERED FROM OUR STUDIES WILL ASSIST THE DESIGN OF THERAPEUTICS TARGETING SPECIFIC CASR MUTATIONS AND GUIDE PRECISION MEDICINE EFFORTS IN THE FUTURE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $205.6k | 8/5/25 | ||
| Not listed | $246.8k | 7/30/24 |